Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Liabilities from Discontinued Operations (2022)

Historic Liabilities from Discontinued Operations for Regenerative Medical Technology (RMTG) over the last 1 years, with Q4 2022 value amounting to $68313.0.

  • Regenerative Medical Technology's Liabilities from Discontinued Operations changed N/A to $68313.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $68313.0, marking a year-over-year change of. This contributed to the annual value of $68313.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, Regenerative Medical Technology's Liabilities from Discontinued Operations is $68313.0.
  • Over the past 5 years, Regenerative Medical Technology's Liabilities from Discontinued Operations peaked at $68313.0 during Q4 2022, and registered a low of $68313.0 during Q4 2022.